Hudsjukdomar – Lennart Emtestam grupp

Publikationer

Utvalda publikationer

• Editorial comment: BRITISH JOURNAL OF DERMATOLOGY. 2021;184(5):796-798

  A growing family of outcome measurement proposals for hidradenitis suppurativa

  Emtestam L; Lapins J; Sartorius K
• Article: ARCHIVES OF DERMATOLOGICAL RESEARCH. 2020;312(10):715-724

  Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients

  Riis PT; Saunte DM; Sigsgaard V; Villani AP; Guillem P; Pascual JC; Kappe NN; Vanlaerhoven AMJD; van der Zee HH; Prens EP; El-Domyati M; Abdel-Wahab H; Moftah N; Abdelghani R; Agut-Busquet E; Romani J; Hlela C; van den Worm L; Bettoli V; Calamo G; Gurer MA; Beksac B; Matusiak L; Glowaczewska A; Szepietowski JC; Emtestam L; Lapins J; Kottb HR; Fatani M; Weibel L; Theiler M; Delage-Toriel M; Thi THL; Nassif A; Becherel P-A; Dolenc-Voljc M; Doss N; Bouazzi D; Benhadou F; del Marmol V; Jemec GBE
• Article: DERMATOLOGY. 2020;236(4):281-288

  Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients

  Killasli H; Sartorius K; Emtestam L; Svensson A
• Article: BRITISH JOURNAL OF DERMATOLOGY. 2018;178(3):715-721

  Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II

  Thorlacius L; Garg A; Ingram JR; Villumsen B; Riis PT; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernandez-Penas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
• Editorial comment: BRITISH JOURNAL OF DERMATOLOGY. 2018;178(3):591-592

  Interleukin-36 cytokine family signalling in hidradenitis suppurativa

  Emtestam L; Sartorius K
• Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2018;32(2):307-312

  Low and high body mass index in hidradenitis suppurativa patientsdifferent subtypes?

  Riis PT; Saunte DM; Benhadou F; del Marmol V; Guillem P; El-Domyati M; Abdel-Wahab H; Antoniou C; Dessinioti C; Gurer MA; Beksac B; Szepietowski JC; Matusiak L; Emtestam L; Lapins J; Riad H; Doss N; Massa AF; Hamzavi I; Nicholson C; Dolenc-Voljc M; Kim KH; Ohn J; Zouboulis CC; Karagiannidis I; Mokos ZB; Durinec P; Jemec GBE
• Editorial comment: BRITISH JOURNAL OF DERMATOLOGY. 2017;177(3):625-627

  Glucagon-like peptide-1 agonists for treatment of hidradenitis suppurativa

  Emtestam L; Sartorius K
• Letter: DERMATOLOGIC SURGERY. 2017;43(4):604-605

  Carbon Dioxide Laser Treatment Using Methylene Blue-Assisted Sinus Tract Identification in Hidradenitis Suppurativa

  Emtestam L; Lapins J; Sartorius K
• Article: JOURNAL OF AMERICAN ACADEMY OF DERMATOLOGY. 2016;75(6):1151-1155

  Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series

  Riis PT; Boer J; Prens EP; Saunte DML; Deckers IE; Emtestam L; Sartorius K; Jemec GBE

Medarbetare och kontakt

Gruppledare

• 

  Lennart Emtestam

  Telefon +46852486072

  E-postadress lennart.emtestam@ki.se

Alla medarbetare i gruppen

• 

  Lennart Emtestam

  Telefon +46852486072

  E-postadress lennart.emtestam@ki.se